2,5-anhydromannitol has been researched along with cytarabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SJ; Chen, WL; Chen, Z; Cheng, Z; Jia, W; Liu, J; Ni, Y; Qu, C; Rajani, C; Su, M; Wang, YY; Wei, R; Xia, L; Xie, G; Zhao, A; Zhao, L | 1 |
1 other study(ies) available for 2,5-anhydromannitol and cytarabine
Article | Year |
---|---|
Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.
Topics: Animals; Cell Line, Tumor; Cytarabine; Drug Synergism; Fructose; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose Transporter Type 5; Humans; Leukemia, Myeloid, Acute; Mannitol; Mice; Prognosis; Treatment Outcome; Up-Regulation | 2016 |